Minerva Neurosciences, Inc. Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment
Minerva Neurosciences, Inc. (NERV) had Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment of $3.00 million as of 2020-06-30, per its 10-Q filed 2020-08-03.
Discontinued › Notes
us-gaap:HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment · last filed 2021-03-08
- 2020-06-30: Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment $3.00M.
- 2020-03-31: Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment $7.48M.
- 2019-12-31: Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment $24.44M.
- 2019-09-30: Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment $22.03M.
| Period end | Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment |
|---|---|
| 2020-06-30 | $3.00M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $7.48M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $24.44M 10-K · filed 2021-03-08 |
| 2019-09-30 | $22.03M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $41.45M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $48.56M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $37.76M 10-K · filed 2020-03-09 |
| 2018-09-30 | $10.31M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $39.80M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $75.87M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $107.13M 10-K · filed 2019-03-12 |
| 2017-09-30 | $107.03M 10-Q · filed 2017-11-06 |
| 2016-06-30 | $8.39M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $9.82M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $17.92M 10-K · filed 2016-03-14 |
| 2015-09-30 | $22.06M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $23.09M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |